Therapeutic strategies in nonalcoholic fatty liver disorders

Resultado de la investigación: Review articlerevisión exhaustiva

1 Cita (Scopus)


Non-alcoholic fatty liver disease (NAFLD) is the most common liver disorder in developing countries. Many of the risk factors are well defined, but the underlying pathogenesis is not well understood. The demographics of the condition mirror those of the metabolic syndrome, with obesity and insulin resistance being the most commonly associated conditions. At present, therapy is aimed at correcting the risk factors, but there are no proven therapies at this point.

Idioma originalEnglish (US)
Páginas (desde-hasta)237-239
Número de páginas3
PublicaciónExpert Opinion on Emerging Drugs
EstadoPublished - may 1 2005
Publicado de forma externa

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)


Profundice en los temas de investigación de 'Therapeutic strategies in nonalcoholic fatty liver disorders'. En conjunto forman una huella única.

Citar esto